about
The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cellsBatimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.TIMP-2 modulates cancer cell transcriptional profile and enhances E-cadherin/beta-catenin complex expression in A549 lung cancer cellsLess is more: low expression of MT1-MMP is optimal to promote migration and tumourigenesis of breast cancer cells.Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.Mammographic density and matrix metalloproteinases in breast tissue.Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment.Matrix metalloproteinase-7 expression in gastric carcinoma.Role of matrix metalloproteinase (MMP) 2 and MMP-9 in soft tissue sarcoma.Complex roles of tissue inhibitors of metalloproteinases in cancer.Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation.Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.Matrix metalloproteinases and their inhibitors in gastric cancer.Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.Matrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour.Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinomaDensity-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells.Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesionsComparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.Imbalance between serum matrix metalloproteinase-2 and its inhibitor as a predictor of recurrence of urothelial cancer.Inhibitory effects of malotilate on invasion and metastasis of rat mammary carcinoma cells by modifying the functions of vascular endothelial cells.Immunohistochemical expression of SKALP/elafin in squamous cell carcinoma of the oesophagusTargeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro.Tissue inhibitor of metalloproteinases-1 (TIMP-1) mRNA is elevated in advanced stages of thyroid carcinoma.A new superinvasive in vitro phenotype induced by selection of human breast carcinoma cells with the chemotherapeutic drugs paclitaxel and doxorubicin.Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines.Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancyReduced tissue inhibitor of metalloproteinase-2 expression is associated with advanced medullary thyroid carcinoma.Gelatinase A activity directly modulates melanoma cell adhesion and spreading.Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.TIMP-1 overexpression in lung carcinoma enhances tumor kinetics and angiogenesis in brain metastasis.Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2.Effect of Thuja occidentalis and its polysaccharide on cell-mediated immune responses and cytokine levels of metastatic tumor-bearing animals.Regulation of MMP-2 expression and activity by β-1,3-N-acetylglucosaminyltransferase-8 in AGS gastric cancer cells.Timp-2 binding with cellular MT1-MMP stimulates invasion-promoting MEK/ERK signaling in cancer cells.Tissue inhibitor of metalloproteinases-2 binding to membrane-type 1 matrix metalloproteinase induces MAPK activation and cell growth by a non-proteolytic mechanism.
P2860
Q21093314-EF750D47-A735-4FBC-8CB4-12BA0E00F582Q27732644-9E8D87A6-5A41-4C25-A06D-7F888BE0A6ADQ28385210-513A7A43-CED6-495D-8101-55B07D3C1B10Q30824578-1FCD49AD-3FBF-4120-9316-389BE5DB21F6Q32159522-1B09BB6A-B6BD-46E3-9554-E90BCA0B08D0Q34268721-D30581EF-C69A-4506-94F2-22E786A3660BQ34402072-C4224115-E295-4D0F-AD2B-3E62E9E6B488Q34410387-467CDE94-0301-47F4-84CE-E18F4BBA5A07Q34518846-A05BA6CD-C488-49D9-A1A4-043E5903686AQ34596110-D6247339-3B82-489F-A24F-3497DA38895DQ35031677-8A76E1E7-4473-4C2D-AEFF-6EF7C2C90CF6Q35120530-D407DC3E-143F-47DD-A7C8-925137DBD21AQ35353488-2B13CFC5-0646-4206-A1D6-9D6702E7D96FQ35475215-0C31D1AC-EE18-4ACB-8545-CA9A63690166Q35575178-55B08FEB-0CE2-4920-89E7-CE3207F121CCQ35653181-A261DFC6-7323-48D3-A390-6356A3BC5AD0Q35746324-52B3E687-427F-4AED-9583-A07B4EFF3FF2Q35782463-EF6437AB-CC56-4FB9-9E7D-AFCF0136ADDBQ35833895-9A56055A-683A-4D37-A3F7-DDEBAD59B35FQ35842033-7FE1DF6C-DE25-4133-A53D-6C02BD2091D1Q36029913-A7C24394-3AE6-42E3-894F-E6CCD1AF5B08Q36135135-522F42DC-CE90-4AF5-9CDC-79B17DE5B40EQ36291671-3E7CCF68-99C1-4610-B76C-2F1336EF17CCQ36292528-F63BB60E-A735-4EC9-A64F-1956EA2007E4Q36431252-3C14FB0B-D0AD-4B79-9BEB-F350AEF00A93Q36531663-9DFE4108-AF96-46C8-A434-95A8B0609051Q36617452-6B461E42-B951-46AD-845B-5165401EB597Q36696272-F555B55E-35A6-44C2-81D9-F585A73F031BQ36805538-40632E0F-4816-428A-938F-F5086BA11111Q36840365-AD7A45DE-932E-4C7A-9A4E-33C29881F9EDQ37465475-71B974FA-7F85-4325-B54A-B60E53DBCBC9Q37574813-C9641608-AAEC-4E83-A691-FD3747FAE17BQ37694676-3D2225F3-2AF3-462D-8ADD-19B836A74642Q37875244-FE7E6458-1520-4617-8AE8-EEAD8FDBE4CEQ38901634-9800D758-652D-4556-B41A-9FA68FDF471AQ39007403-9468A511-0996-4EC7-B351-A824D410B0B9Q39540441-145E16BC-0F31-4534-9C6D-CBFB4368C7CBQ39641629-64FCE043-E3DC-4B50-85CD-8BBDA303BCB4Q39833926-B410D827-F548-45BA-BAFA-627D1E07AE98Q40054421-C190DE7B-CB2B-436E-9BDD-DA0CDEEE1FD0
P2860
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Tumor cell invasion inhibited by TIMP-2.
@en
type
label
Tumor cell invasion inhibited by TIMP-2.
@en
prefLabel
Tumor cell invasion inhibited by TIMP-2.
@en
P2093
P356
P1476
Tumor cell invasion inhibited by TIMP-2.
@en
P2093
Melchiori A
Stetler-Stevenson WG
P304
P356
10.1093/JNCI/83.11.775
P407
P577
1991-06-01T00:00:00Z